title: Chemotherapy plus ponatinib: a new standard for Ph-positive ALL?
authors.affiliation: Hospices Civils de Lyon, Hematology, Lyon-Sud Hospital, Bât. 1G, 69495 Pierre Bénite, France. Electronic address: xavier.thomas@chu-lyon.fr.
authors.forename: Xavier
authors.initials: X
authors.lastname: Thomas
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011724:Pyridazines / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D011724:Pyridazines